HenryCharlesBodenheimerJr.MDFACP, FAASLD, FAGA,FNYAM
Gastroenterology • Locust Valley, NYHepatology & Liver Transplantation
Clinical Professor of Medicine Zucker School of Medicine at Hofstra/Northwell
Dr. Bodenheimer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11 Beaver Dr
Locust Valley, NY 11560Phone+1 917-991-6171Fax+1 516-748-8514
Summary
- Dr. Henry Bodenheimer is a gastroenterologist in Locust Valley, NY. He is Clinical Professor of Medicine at Zucker School of Medicine at Hofstra/Northwell. He received his medical degree from Tufts U. He specializes in hepatology & liver transplantation and is experienced in primary biliary cholangitis, viral hepatitis, and biliary disease.
Education & Training
Brown UniversityFellowship, Gastroenterology, 1979 - 1981
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 1978 - 1979- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1976 - 1978
- Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1975 - 1976
Tufts University School of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 1976 - 2024
RI State Medical License 1980 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2006
- Fellow New York Academy of Medicine
- Super Doctor SuperDoctors.com
Clinical Trials
- Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy Start of enrollment: 2005 Dec 01
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver Start of enrollment: 2006 Jan 01
Publications & Presentations
PubMed
- 69 citationsAssociation of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genesGideon M. Hirschfield, Gang Xie, Emily Y. Lu, Ye Sun, Brian D. Juran
Genes and Immunity. 2012-01-19 - 124 citationsImmunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis b...Brian D. Juran, Gideon M. Hirschfield, Pietro Invernizzi, Elizabeth J. Atkinson, Yafang Li
Human Molecular Genetics. 2012-12-01 - 2243 citationsPeginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.Stephanos J. Hadziyannis, Sette H, Timothy R. Morgan, Balan, Moisés Diago
Annals of Internal Medicine. 2004-03-02
Press Mentions
State Gives Preliminary OK to Long Island’s First Liver Transplant ProgramFebruary 27th, 2018
State Gives Preliminary OK to Long Island's First Liver Transplant ProgramFebruary 20th, 2018
Professional Memberships
- Fellow
- Member
- Fellow
- American Association for the Study of Liver DiseasesFellow
Industry Relationships
- Consultant, Pliant Therapeutics2023 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
